Tuberculosis: all 1,435 studies
Page 12 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy AdultsCompletedNCT01574638Phase 1
- Determining Risk in Latent TuberculosisTerminatedNCT01571739
- Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or RifampinCompletedNCT01571414Phase 1
- Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural EffusionCompletedNCT01560078
- Trial of Point-of-treatment Xpert MTB/RIF AssayCompletedNCT01554384Not applicable
- TB mHealth Study - Use of Cell Phones to Improve Compliance in Patients on LTBI TreatmentStatus unknownNCT01549457Early Phase 1
- Effect of Filarial Infection on Immune Responses in Latent TuberculosisCompletedNCT01547884
- Utility of Sputum Induction and Novel Technologies to Improve TB Diagnosis in a High HIV Prevalence Primary Care SettingCompletedNCT01545661Not applicable
- Tuberculosis Recurrence Upon Treatment With Highly Active Antiretroviral TherapyCompletedNCT01539005
- Gene Xpert Diagnosis of TB Using Tracheal Aspirates From Intensive Care Unit (ICU) PatientsCompletedNCT01530568Not applicable
- Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of TuberculosisStatus unknownNCT01525134Not applicable
- Intensive Smoking-cessation Intervention Versus Smoking-cessation Advice in Smear-positive Patients With Pulmonary TuberculosisCompletedNCT01517022Phase 3
- Phase 2a EBA Trial of AZD5847CompletedNCT01516203Phase 2
- Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's DiseaseStatus unknownNCT01503099
- Safety of Tuberculosis Vaccine, MVA85A, Administered by the Aerosol Route and the Intradermal RouteCompletedNCT01497769Phase 1
- Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, UgandaCompletedNCT01492595
- Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South AfricaCompletedNCT01479972Phase 2
- Treatment Adherence of Tuberculosis MedicinesCompletedNCT01471977Not applicable
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary TuberculosisApproved for marketingNCT01464762
- Comparison of Door-to-door Versus Community Gathering to Provide HIV Counseling and Testing Services in Rural LesothoCompletedNCT01459120Not applicable
- Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced HepatotoxicityCompletedNCT01456845
- Chepetsa TB - Reducing TB Among HIV-Infected MalawiansCompletedNCT01450085Not applicable
- Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment TrialWithdrawnNCT01442428Phase 2/3
- Effect of Prophylactic Use of Silymarin on Hepatotoxicity Induced by Anti-tuberculosis DrugsStatus unknownNCT01436929Not applicable
- Evaluating Diagnostics for Paediatric Tuberculosis by Blood CultureCompletedNCT01434758
- Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral TreatmentCompletedNCT01433796
- The Effect of Intermittent Rifampicin on RaltegravirCompletedNCT01424826Phase 1
- An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, UgandaCompletedNCT01422798
- Prevention of Early Mortality by Presumptive Tuberculosis (TB) TreatmentTerminatedNCT01417988Phase 4
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)Status unknownNCT01398618Phase 3
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentStatus unknownNCT01395654Phase 4
- Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TBCompletedNCT01392911Phase 2
- Development of a Prediction Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's DiseaseCompletedNCT01392365
- Access to Care and Adherence Tuberculosis (TB) SurveyCompletedNCT01390987
- Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in MaliTerminatedNCT01381757
- Tuberculosis (TB) Immunotherapy Phase 2 StudyCompletedNCT01380119Phase 2
- Tuberculosis Volatile Organic CompoundsCompletedNCT01379066
- A Study to Evaluate Safety and Immunogenicity of AERAS-402CompletedNCT01378312Phase 1
- Conversion Rate of (TST) Tuberculin Skin Test and Quantiferon-TB Gold In Tube Assay in Health Care WorkersCompletedNCT01376843
- Diagnosis of Tuberculous Meningitis by ESAT-6 in CSFCompletedNCT01371916
- Tiotropium in Patients With Tuberculosis (TB) Destroyed LungStatus unknownNCT01365702
- Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized PatientsCompletedNCT01364324
- Phase IC Study of Safety and PK of SQ109 300mg DailyCompletedNCT01358162Phase 1
- A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, MalawiCompletedNCT01356095Not applicable
- Role of EBUS-TBNA in Diagnosing TB in Mediastinal/Hilar Lymph NodesSuspendedNCT01350674Not applicable
- Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.Status unknownNCT01344148Not applicable
- TMC207 +/- Rifabutin/RifampinCompletedNCT01341184Phase 1
- Study of AERAS 422 in Healthy AdultsCompletedNCT01340820Phase 1
- Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)CompletedNCT01331811Not applicable
- Pharmacokinetics and Safety of MoxifloxacinTerminatedNCT01329250Phase 4
- Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical SpecimensStatus unknownNCT01322685
- Study Of The Long Term Outcome Of Tuberculous Meningitis In Vietnamese Adults Treated With Adjunctive DexamethasoneCompletedNCT01317654
- Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for TuberculosisStatus unknownNCT01315301Not applicable
- Surveillance and Follow-up for Latent Tuberculosis Infection and Risk of Developing Active Tuberculosis in Patients Receiving Long-term DialysisCompletedNCT01311999
- Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary TuberculosisCompletedNCT01301144
- Enhanced Tuberculosis Case Detection Among Substitution Treatment PatientsCompletedNCT01290081Not applicable
- Vitamin D Supplementation Enhances Immune Response to Bacille-Calmette-Guerin (BCG) Vaccination in InfantsCompletedNCT01288950Not applicable
- Characterization and Evaluation of Diagnostic Biomarkers for TuberculosisCompletedNCT01269268
- Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary TuberculosisCompletedNCT01252992
- Immunosuppression in HIV-infected Patients With Tuberculosis in EthiopiaCompletedNCT01252537
- Efficacy of Antituberculous Therapy in Management of SarcoidosisCompletedNCT01245036Not applicable
- Role of Vitamin D in Innate Immunity to TuberculosisCompletedNCT01244204Not applicable
- Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary TuberculosisCompletedNCT01242592Phase 2
- A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCGCompletedNCT01242475Phase 2
- A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB)CompletedNCT01241188Phase 2
- PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood AssayCompletedNCT01225640Phase 2
- Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With PsoriasisStatus unknownNCT01223976Phase 4
- QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.CompletedNCT01223534Phase 4
- Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV PatientsCompletedNCT01222338Phase 2
- Early Bactericidal Activity (EBA) of SQ109 in Adult Subjects With Pulmonary TBCompletedNCT01218217Phase 2
- A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy SubjectsCompletedNCT01214993Phase 1
- Operational Assessment of Laboratory Information System for MDR-TB in Lima, PeruCompletedNCT01201941
- A BCG Challenge Model Study to Assess Anti-mycobacterial Immunity Induced by BCG and a Candidate TB Vaccine, MVA85ACompletedNCT01194180Phase 1
- The Incidence and Risk Factors of Side Effects During the Initial Phase of Rifater Therapy - a Prospective StudyStatus unknownNCT01182259
- Safety of Tuberculosis Vaccine, MVA85A, Administered by the Intramuscular Route and the Intradermal RouteCompletedNCT01181856Phase 1
- The Role of Routine Bacterial Culture Including Tuberculosis During Bronchoscopy: A Prospective StudyCompletedNCT01167647
- Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis InfectionCompletedNCT01162265
- Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability StudyCompletedNCT01158755Phase 2
- Endobronchial Ultrasound Guided Transbronchial Aspiration (EBUS-TBNA) in Non Small Cell Lung Cancer (NSCLC) in a Tuberculosis-endemic CountryCompletedNCT01156623Not applicable
- Latency in Pulmonary TuberculosisCompletedNCT01154959Phase 3
- Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis TherapyCompletedNCT01138202Phase 2
- Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis InfectionCompletedNCT01136161Phase 2
- Simple Verbal Intervention for Adequately Collecting SputumStatus unknownNCT01135043Phase 4
- Replacement of Vitamin D in Patients With Active TuberculosisCompletedNCT01130311Not applicable
- Treatment Duration for Abdominal TuberculosisCompletedNCT01124929Phase 3
- Diagnosis of Mediastinal Tuberculous Lymphadenopathy by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA)Status unknownNCT01121432
- Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) PatientsCompletedNCT01121068
- Study of Pre-clearance of Latent Tuberculosis Infection And BCG RevaccinationCompletedNCT01119521Phase 1
- Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison to BCG in Healthy Volunteers in South AfricaCompletedNCT01113281Phase 1
- Prevalence of Latent Tuberculosis (TB) Infection Diagnosed by Interferon-gamma Release Assay and Tuberculin Skin Tests in Patients With Old Healed TBCompletedNCT01099098
- Isoniazid (INH) Treatment Based on ELISPOT AssayCompletedNCT01087190Not applicable
- Tuberculosis in ChinaCompletedNCT01071603
- Adjunct Immunotherapy With Immunoxel in Patients With TB and TB/HIVCompletedNCT01061593Phase 3
- Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected PatientsCompletedNCT01059422Phase 4
- Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv SettingCompletedNCT01053598
- A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31)CompletedNCT01049282Phase 1
- Effectiveness of Music TherapyStatus unknownNCT01040611Not applicable
- QuantiFERON Change During Anti-tuberculosis MedicationCompletedNCT01038830
- A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active TuberculosisCompletedNCT01033929Phase 1
- Latent Tuberculosis Infection in Bone Marrow Transplant RecipientsCompletedNCT01021124